Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entity

Parker Waichman LLP

Tracked across 1 events · 7 articles · First seen May 22, 2026 · Last active Jun 09, 2026

Sentiment
70
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
4 70
Regulatory
Parker Waichman LLP has filed multiple lawsuits against pharmaceutical giants Novo Nordisk and Eli Lilly and Company, alleging that their popular GLP-1 receptor agonist medications, Semaglutide, Semaglutide, Tirzepatide, and Tirzepatide, caused Non-Arteritic Anterior Ischemic Optic…
Impact: Parker Waichman LLP is a national law firm that has filed multiple lawsuits against pharmaceutical companies, representing individuals who developed NAION after taking GLP-1 medications. The firm is actively seeking more clients for these cases.
May 22, 2026 · 7 articles
NEWSDESK
Track Parker Waichman LLP live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.